Condensed Consolidated Statement of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net loss	$ (378,284)	$ (1,263,163)	[1]
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	36,610	17,968
Stock-based compensation	134,474	1,259,336
Loss on equity method investments	1,516	31,053	[1]
Loss on investments	8,491	38,223	[1]
Change in fair value of warrant liabilities	3,278	(108,544)	[1]
Change in fair value of contingent consideration liability	8,453	300
Gain on deconsolidation of subsidiaries (Note 6)	0	(15,900)	[1]
Impairment loss on assets held for sale	9,001	0
Non-cash customer consideration	(353)	(18,139)
Non-cash lease expense	16,327	7,536
Amortization of finance lease right-of-use assets	569	1,004
Non-cash in-process research and development	3,981	1,162
Other non-cash activity	2,213	502
Changes in operating assets and liabilities:
Accounts receivable ($659 and $1,345 from related parties)	15,397	(38,598)
Prepaid expenses and other current assets	9,538	4,373
Inventory	2,549	(4,740)
Operating lease right-of-use assets	4,096	0
Other non-current assets	(2,426)	(419)
Accounts payable	2,993	10,650
Accrued expenses and other current liabilities	(6,997)	(12,881)
Deferred revenue, current and non-current ($(7,718) and $(14,667) from related parties)	(21,372)	(19,708)
Operating lease liabilities, current and non-current	(13,250)	(5,332)
Other non-current liabilities	(922)	(3,989)
Net cash used in operating activities	(164,118)	(119,306)
Cash flows from investing activities:
Cash acquired in acquisition	0	1,440
Purchase of convertible note	0	(6,500)
Purchases of property and equipment	(32,974)	(13,153)
Proceeds from sale of held for sale assets	2,926	0
Prepayment for marketable equity securities	0	(3,691)
Deconsolidation of subsidiary - cash	0	(28,772)
Other	(590)	(49)
Net cash used in investing activities	(30,638)	(50,648)
Cash flows from financing activities:
Principal payments on finance/capital leases and lease financing obligation	(648)	(609)
Contingent consideration payment	(1,042)	(521)
Other	(579)	(905)
Net cash provided by financing activities	(2,269)	(2,035)
Effect of foreign exchange rates on cash and cash equivalents	(495)	(104)
Net (decrease) increase in cash, cash equivalents and restricted cash	(197,520)	(172,093)
Cash and cash equivalents, beginning of period	1,315,792	1,550,004
Restricted cash, beginning of period	53,789	42,924
Cash, cash equivalents and restricted cash, beginning of period	1,369,581	1,592,928
Cash and cash equivalents, end of period	1,105,787	1,377,152
Restricted cash, end of period	66,274	43,683
Cash, cash equivalents and restricted cash, end of period	1,172,061	$ 1,420,835
Supplemental disclosure of non-cash investing and financing activities:
ROU assets obtained in exchange for new operating lease liabilities upon adoption of ASC 842	0
ROU assets obtained in exchange for new finance lease liabilities upon adoption of ASC 842	0
ROU asset obtained in exchange for new operating lease liabilities	13,649
ROU Asset obtained in exchange for new finance lease liabilities	0
Equity received in related parties	0
Settlement of contingent consideration - restricted stock	$ 2,262

[1] As adjusted to reflect the impact of the adoption of Accounting Standards Codification Topic 842, Leases (“ASC 842”) as of January 1, 2022. See Note 1 for a summary of the adjustments.